Home drug plans Page 19

Keyword: drug plans

391 results found
How three benefits plan members are receiving medical cannabis coverage

While medical cannabis coverage is appearing in more benefits plans, most insurers that cover it still have very specific conditions. Sun Life Canada covers the most conditions, at seven, after adding two ailments to its roster in 2019. Marie-Chantal Côté, the insurer’s vice-president of market development for group benefits, says evidence is emerging that shows […]

Medavie Blue Cross launching drug management solution

Medavie Blue Cross is launching a new drug management solution that will offer broader drug coverage while aiming to lower costs for group benefits plan members. The program, Rxperience, offers plan members open access to traditional drug benefits and specialty drug management via increased standardized core benefits, according to a press release. Read: Medavie Blue Cross […]

  • By: Staff
  • October 14, 2020 October 14, 2020
  • 15:15

Benefits by Design Inc. and PocketPills are partnering on a digital pharmacy platform. Through the partnership, group plan members will be able to instantly connect with pharmacists and manage their medications online. PocketPills’ platform includes automation technology that improves the pharmacy workflow, making pharmacists more accessible to patients via phone or live chat, seven days a […]

  • By: Staff
  • October 6, 2020 December 6, 2020
  • 15:15
How are insurers using block-level contract amendments to control drug costs?

An upcoming Sun Life Canada drug plan change that will be implemented outside of plan sponsors’ renewal periods is calling attention to the practice of block-level contract amendments. Sun Life is set to implement the first phase of its reference drug program on Oct. 1, which the insurer says will help plan sponsors with drug plan sustainability by creating categories […]

Over the past four years, total drug costs adjudicated by HBM+ have risen from about $1.2 billion to $1.5 billion, while the number of claimants has increased from 1.7 million to more than two million. The inaugural drug trends and strategic insights report by the health benefits manager, a division of Green Shield Canada, examined drug […]

  • By: Staff
  • September 18, 2020 November 17, 2020
  • 15:00
Hyundai Canada addresses coronavirus with mental-health, connectivity initiatives

The coronavirus pandemic has altered the landscape of Canadian workplaces. Now, more than ever, communication and compassion are imperative for employees to feel secure and supported by their employers. Before the pandemic arrived in Canada, Hyundai Auto Canada Corp. accelerated its emphasis on mental wellness in January 2020 by tripling its mental-health coverage (from an […]

Coronavirus pandemic drives 20% increase in new claims for mental-health drugs

Claims for medications treating mental-health issues like anxiety and depression reached 97 per cent of 2019’s total claims volume by the end of August 2020, according to new data from Express Scripts Canada. In addition, 2020 has seen a 20 per cent increase in claimants for medications relating to depression compared to 2019. “For the remainder of […]

Canadians received a record $103 billion in benefits from life and health insurers last year, up 60 per cent from a decade earlier, according to the Canadian Life and Health Insurance Association’s annual fact book. The benefits include $53.3 billion in pension annuity payments, $38.1 billion in health benefits for prescription drugs and supplementary health […]

  • By: Staff
  • September 16, 2020 November 30, 2020
  • 09:00
Plan Sponsor Week: Using analytics to monitor non-adherence, disease states

Plan sponsors have to move beyond benefits plan reporting and dig into analytics to better understand medication non-adherence and the top disease states affecting their workforces. “Leveraging plan-specific data can help answer the fundamental questions needed to manage your benefits program,” said Shawn O’Brien, Telus Health’s principal of data enablement and drug, health, dental product roadmaps, during a session at Benefits […]

Rare disease drugs strategy, standard coverage in CLHIA’s 2020 budget wish list

The Canadian Life and Health Insurance Association is recommending the federal government develop a strategy for high-cost drugs for rare diseases, potentially by harmonizing catastrophic drug coverage across the country. In its August federal budget submission to the standing committee on finance, the association noted specialty drugs, including those for chronic and rare disease, made up just two […]

  • By: Staff
  • August 12, 2020 November 12, 2020
  • 15:00